skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi team,
In the US small caps in the growth mode, which are your current favorites ? Any views on FTHM-Q, CTRN-Q, ROAD-Q ?
Gratefully,
J IDS
Read Answer Asked by Jacques on January 25, 2021
Q: Good Day,

Currently I have approximately $72 000 invested and I am working toward ensuring that my portfolio is diversified. Your portfolio analytics tool has informed me that I need more international exposure. I recently read an article about investing in small cap ETFs now in order to realize potential gains down the road. I am wondering what you would recommend for small cap ETFs?

Regards,

Ryan
Read Answer Asked by Ryan on January 25, 2021
Q: Hello 5i,
Can provide and info on this company?
Thanks
Dave
Read Answer Asked by Dave on January 25, 2021
Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Read Answer Asked by Charles on January 25, 2021
Q: I know that you are not a fan of this company. Have you looked at it after there last quarter. To me it just looks like where we will do things in the future and how. Seems to do more than a Uber and a DoorDash. Could it be something in the future like when Amazon and Tesla and everybody told us not to touch them in there early days? Too much debt, no earnings, over valued, to much risk. What do you think?
Thanks Again
Read Answer Asked by eugene on January 22, 2021
Q: Morning 5i,
I bought FTG in mid 2017 at $4.55 as it was trending upwards, but then watched (and held on) as it slipped and slipped to a low of approximately $2.00 in early 2019. I then watched some more as it rose steadily through 2019 to peak at $4.21 in early January, 2020 - leading me to naively hope my loyalty might soon be rewarded - only to watch it crash mercilessly in Feb and March 2020. I think it had started that downward trajectory before COVID took hold and, at least initially, I don't think its decline was due to the pandemic.
I went through something similar with BUS, held on devotedly, and I'm now being rewarded as it has just recently exceeded my long ago purchase price and rightly or wrongly I think its future is rather bright.
My question - do you see any prospect for FTG to have the sort of resurgence that BUS has recently had (I know that apart from the rocky road they've both been treading over the past 3 or so years they have little in common, and also that FTG is significantly smaller) or would I be well advised to take my lumps and deploy the (now considerably less) money elsewhere.
Thanks, as always, for your thoughts and advice.
Peter
Read Answer Asked by Peter on January 22, 2021
Q: I'd appreciate your views on Xphyto Therapeutics, a company based in B.C. but with important partnerships in Germany. They appear to have a couple of very promising irons in the fire, including a portable PCR test for Covid-19.
Read Answer Asked by Richard on January 22, 2021
Q: I already own XBC, and have been looking at GRN it has moved up a bit lately. Is it a buy? Was just wondering how much difference there was in these two companies. XBC seems to be more into the hydrogen and cleaning of gases. Is GRN more into RNG equipment and installations. I know you really like XBC and was wondering whether it would be suitable to buy GRN. Or do you have another company in the same field that might be better or should I just add to my XBC.
Thanks John
Read Answer Asked by John on January 20, 2021
Q: Hello Peter, Ryan, and 5i Team,

I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
Read Answer Asked by Bradley on January 20, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!